{
  "schema_version": "2.0",
  "doc_id": "80e0d273288af7f8b8747a050c40a9f4dadea6d8622210d259688d928c752eaf",
  "extracted_at": "2026-02-01T08:44:47.386211+00:00",
  "extractor": "legacy-migration",
  "entities": [
    {
      "id": "ent_001",
      "type": "PharmEffect",
      "name": "Immunomodulatory effects",
      "attributes": {
        "context": "Immunomodulatory effects of Sceletium tortuosum"
      },
      "source_chunk_ids": [
        "ee66687e5d404840448a7c80782ff97e"
      ]
    },
    {
      "id": "ent_002",
      "type": "Taxon",
      "name": "Sceletium tortuosum",
      "attributes": {
        "context": "Immunomodulatory effects of Sceletium tortuosum"
      },
      "source_chunk_ids": [
        "ee66687e5d404840448a7c80782ff97e"
      ]
    },
    {
      "id": "ent_003",
      "type": "Compound",
      "name": "Trimesemine\u2122",
      "attributes": {
        "context": "Sceletium tortuosum (Trimesemine\u2122)"
      },
      "source_chunk_ids": [
        "ee66687e5d404840448a7c80782ff97e"
      ]
    },
    {
      "id": "ent_004",
      "type": "Indication",
      "name": "chronic disease",
      "attributes": {
        "context": "Implications for chronic disease"
      },
      "source_chunk_ids": [
        "ee66687e5d404840448a7c80782ff97e"
      ]
    },
    {
      "id": "ent_005",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "Sceletium exerts significant cytoprotective effects"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_006",
      "type": "PharmEffect",
      "name": "cytoprotective effects",
      "attributes": {
        "context": "exerts significant cytoprotective effects"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_007",
      "type": "Compound",
      "name": "endotoxin",
      "attributes": {
        "context": "setting of endotoxin stimulation"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_008",
      "type": "Compound",
      "name": "Cytokine",
      "attributes": {
        "context": "Cytokine assessment indicated"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_009",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "Sceletium possesses mild anti-inflammatory properties"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_010",
      "type": "PharmEffect",
      "name": "anti-inflammatory properties",
      "attributes": {
        "context": "possesses mild anti-inflammatory properties"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_011",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "Sceletium may be beneficial for the attenuation"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_012",
      "type": "PharmEffect",
      "name": "attenuation",
      "attributes": {
        "context": "attenuation of cytokine-induced depression"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_013",
      "type": "Compound",
      "name": "cytokine",
      "attributes": {
        "context": "cytokine-induced depression"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_014",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "cytokine-induced depression"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_015",
      "type": "Indication",
      "name": "systemic low-grade inflammation",
      "attributes": {
        "context": "in systemic low-grade inflammation"
      },
      "source_chunk_ids": [
        "c5293d4c0ce3052147f3146ed9e0bef0"
      ]
    },
    {
      "id": "ent_016",
      "type": "Indication",
      "name": "ailments",
      "attributes": {
        "context": "treatment of ailments and disorders"
      },
      "source_chunk_ids": [
        "5b9ef9184b3e5cb991a01d1704656ad1"
      ]
    },
    {
      "id": "ent_017",
      "type": "Indication",
      "name": "disorders",
      "attributes": {
        "context": "treatment of ailments and disorders"
      },
      "source_chunk_ids": [
        "5b9ef9184b3e5cb991a01d1704656ad1"
      ]
    },
    {
      "id": "ent_018",
      "type": "PharmEffect",
      "name": "anti-stress",
      "attributes": {
        "context": "potential anti-stress capacity"
      },
      "source_chunk_ids": [
        "5b9ef9184b3e5cb991a01d1704656ad1"
      ]
    },
    {
      "id": "ent_019",
      "type": "Taxon",
      "name": "Sceletium tortuosum",
      "attributes": {
        "context": "is Sceletium tortuosum"
      },
      "source_chunk_ids": [
        "5b9ef9184b3e5cb991a01d1704656ad1"
      ]
    },
    {
      "id": "ent_020",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "Sceletium extract has been shown"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_021",
      "type": "PharmEffect",
      "name": "monoamine releasing agent",
      "attributes": {
        "context": "effectiveness as monoamine releasing agent"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_022",
      "type": "PharmEffect",
      "name": "selective serotonin reuptake inhibitor",
      "attributes": {
        "context": "selective serotonin reuptake inhibitor"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_023",
      "type": "PharmEffect",
      "name": "limit glucocorticoid production",
      "attributes": {
        "context": "to limit glucocorticoid production"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_024",
      "type": "Compound",
      "name": "glucocorticoid",
      "attributes": {
        "context": "limit glucocorticoid production"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_025",
      "type": "PharmEffect",
      "name": "inhibition of specific adrenal p450 enzymes",
      "attributes": {
        "context": "inhibition of specific adrenal p450 enzymes"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_026",
      "type": "Compound",
      "name": "adrenal p450 enzymes",
      "attributes": {
        "context": "inhibition of specific adrenal p450 enzymes"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_027",
      "type": "Taxon",
      "name": "Sceletium tortuosum",
      "attributes": {
        "context": "crude Sceletium tortuosum extract"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_028",
      "type": "PharmEffect",
      "name": "anxiolytic",
      "attributes": {
        "context": "did exhibit less anxiety behaviour"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_029",
      "type": "PharmEffect",
      "name": "pro-inflammatory",
      "attributes": {
        "context": "pro-inflammatory cytokine"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_030",
      "type": "Compound",
      "name": "interleukin-1-beta",
      "attributes": {
        "context": "interleukin-1-beta (IL-1\\beta)"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_031",
      "type": "Compound",
      "name": "IL-1\\beta",
      "attributes": {
        "context": "interleukin-1-beta (IL-1\\beta)"
      },
      "source_chunk_ids": [
        "6f223d1901bba0e5875218631aee75d7"
      ]
    },
    {
      "id": "ent_032",
      "type": "PharmEffect",
      "name": "anti-depressive",
      "attributes": {
        "context": "anti-depressive and anxiolytic properties"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_033",
      "type": "PharmEffect",
      "name": "anxiolytic",
      "attributes": {
        "context": "anti-depressive and anxiolytic properties"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_034",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "properties claimed for Sceletium"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_035",
      "type": "PharmEffect",
      "name": "immunomodulation",
      "attributes": {
        "context": "exerted via immunomodulation"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_036",
      "type": "PharmEffect",
      "name": "anti-inflammatory effects",
      "attributes": {
        "context": "specifically anti-inflammatory effects"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_037",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_038",
      "type": "Compound",
      "name": "Trimesemine\u2122",
      "attributes": {
        "context": "Sceletium extract, Trimesemine\u2122"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_039",
      "type": "PharmEffect",
      "name": "pro-inflammatory stimulus",
      "attributes": {
        "context": "acute pro-inflammatory stimulus"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_040",
      "type": "Compound",
      "name": "Escherichia coli lipopolysaccharide",
      "attributes": {
        "context": "(Escherichia coli lipopolysaccharide, LPS)"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_041",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "(Escherichia coli lipopolysaccharide, LPS)"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_042",
      "type": "Indication",
      "name": "severe acute inflammatory challenge",
      "attributes": {
        "context": "simulate severe acute inflammatory challenge"
      },
      "source_chunk_ids": [
        "6c73daeedfd85c6bf94064486059b5af"
      ]
    },
    {
      "id": "ent_043",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "Under LPS-challenged conditions"
      },
      "source_chunk_ids": [
        "8d8068530579d19a7c26ceccc8043b2a"
      ]
    },
    {
      "id": "ent_044",
      "type": "Compound",
      "name": "TrimesemineTM",
      "attributes": {
        "context": "neither dose of TrimesemineTM"
      },
      "source_chunk_ids": [
        "8d8068530579d19a7c26ceccc8043b2a"
      ]
    },
    {
      "id": "ent_045",
      "type": "PharmEffect",
      "name": "pro-inflammatory",
      "attributes": {
        "context": "pro-inflammatory cytokine concentrations"
      },
      "source_chunk_ids": [
        "8d8068530579d19a7c26ceccc8043b2a"
      ]
    },
    {
      "id": "ent_046",
      "type": "Compound",
      "name": "IL-6",
      "attributes": {
        "context": "a lower IL-6 response"
      },
      "source_chunk_ids": [
        "8d8068530579d19a7c26ceccc8043b2a"
      ]
    },
    {
      "id": "ent_047",
      "type": "Concentration",
      "name": "high dose",
      "attributes": {
        "context": "after high dose treatment"
      },
      "source_chunk_ids": [
        "8d8068530579d19a7c26ceccc8043b2a"
      ]
    },
    {
      "id": "ent_048",
      "type": "Compound",
      "name": "TrimesemineTM",
      "attributes": {
        "context": "with TrimesemineTM treatment"
      },
      "source_chunk_ids": [
        "8d8068530579d19a7c26ceccc8043b2a"
      ]
    },
    {
      "id": "ent_049",
      "type": "PharmEffect",
      "name": "pro-inflammatory",
      "attributes": {
        "context": "lowering the pro-inflammatory response"
      },
      "source_chunk_ids": [
        "8d8068530579d19a7c26ceccc8043b2a"
      ]
    },
    {
      "id": "ent_050",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "to LPS challenge"
      },
      "source_chunk_ids": [
        "8d8068530579d19a7c26ceccc8043b2a"
      ]
    },
    {
      "id": "ent_051",
      "type": "PharmEffect",
      "name": "anti-inflammatory",
      "attributes": {
        "context": "anti-inflammatory cytokines"
      },
      "source_chunk_ids": [
        "62081d0cfd4bde361c468d5a949cef39"
      ]
    },
    {
      "id": "ent_052",
      "type": "Compound",
      "name": "IL-4",
      "attributes": {
        "context": "IL-4 secretion"
      },
      "source_chunk_ids": [
        "62081d0cfd4bde361c468d5a949cef39"
      ]
    },
    {
      "id": "ent_053",
      "type": "Compound",
      "name": "IL-10",
      "attributes": {
        "context": "basal IL-10 secretion"
      },
      "source_chunk_ids": [
        "62081d0cfd4bde361c468d5a949cef39"
      ]
    },
    {
      "id": "ent_054",
      "type": "Compound",
      "name": "TrimesemineTM",
      "attributes": {
        "context": "TrimesemineTM supplementation"
      },
      "source_chunk_ids": [
        "62081d0cfd4bde361c468d5a949cef39"
      ]
    },
    {
      "id": "ent_055",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "under LPS treated conditions"
      },
      "source_chunk_ids": [
        "62081d0cfd4bde361c468d5a949cef39"
      ]
    },
    {
      "id": "ent_056",
      "type": "PharmEffect",
      "name": "pro-inflammatory",
      "attributes": {
        "context": "pro-inflammatory response"
      },
      "source_chunk_ids": [
        "62081d0cfd4bde361c468d5a949cef39"
      ]
    },
    {
      "id": "ent_057",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "Sceletium's potential immunomodulatory properties"
      },
      "source_chunk_ids": [
        "ec6c5bf503cb29b90c9ea2b2fc6969fa"
      ]
    },
    {
      "id": "ent_058",
      "type": "PharmEffect",
      "name": "immunomodulatory properties",
      "attributes": {
        "context": "Sceletium's potential immunomodulatory properties"
      },
      "source_chunk_ids": [
        "ec6c5bf503cb29b90c9ea2b2fc6969fa"
      ]
    },
    {
      "id": "ent_059",
      "type": "PharmEffect",
      "name": "pro-inflammatory cytokine production",
      "attributes": {
        "context": "investigation of pro- and anti-inflammatory cytokine production"
      },
      "source_chunk_ids": [
        "ec6c5bf503cb29b90c9ea2b2fc6969fa"
      ]
    },
    {
      "id": "ent_060",
      "type": "PharmEffect",
      "name": "anti-inflammatory cytokine production",
      "attributes": {
        "context": "investigation of pro- and anti-inflammatory cytokine production"
      },
      "source_chunk_ids": [
        "ec6c5bf503cb29b90c9ea2b2fc6969fa"
      ]
    },
    {
      "id": "ent_061",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "in the context of Sceletium"
      },
      "source_chunk_ids": [
        "ec6c5bf503cb29b90c9ea2b2fc6969fa"
      ]
    },
    {
      "id": "ent_062",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "mesembrine-rich commercial Sceletium product"
      },
      "source_chunk_ids": [
        "ec6c5bf503cb29b90c9ea2b2fc6969fa"
      ]
    },
    {
      "id": "ent_063",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "commercial Sceletium product"
      },
      "source_chunk_ids": [
        "ec6c5bf503cb29b90c9ea2b2fc6969fa"
      ]
    },
    {
      "id": "ent_064",
      "type": "PharmEffect",
      "name": "inflammatory cytokine production",
      "attributes": {
        "context": "stimulus-induced inflammatory cytokine production"
      },
      "source_chunk_ids": [
        "ec6c5bf503cb29b90c9ea2b2fc6969fa"
      ]
    },
    {
      "id": "ent_065",
      "type": "Compound",
      "name": "cytokines",
      "attributes": {
        "context": "major source of cytokines"
      },
      "source_chunk_ids": [
        "73ea7a58778fa7acc5d9b6cbd6d66966"
      ]
    },
    {
      "id": "ent_066",
      "type": "Compound",
      "name": "IL-1\u03b1",
      "attributes": {
        "context": "including, but not limited to, IL-1\u03b1"
      },
      "source_chunk_ids": [
        "73ea7a58778fa7acc5d9b6cbd6d66966"
      ]
    },
    {
      "id": "ent_067",
      "type": "Compound",
      "name": "IL-1\u03b2",
      "attributes": {
        "context": "IL-1\u03b1, IL-1\u03b2"
      },
      "source_chunk_ids": [
        "73ea7a58778fa7acc5d9b6cbd6d66966"
      ]
    },
    {
      "id": "ent_068",
      "type": "Compound",
      "name": "IL-6",
      "attributes": {
        "context": "IL-1\u03b2, IL-6"
      },
      "source_chunk_ids": [
        "73ea7a58778fa7acc5d9b6cbd6d66966"
      ]
    },
    {
      "id": "ent_069",
      "type": "Compound",
      "name": "IL-8",
      "attributes": {
        "context": "IL-6, IL-8"
      },
      "source_chunk_ids": [
        "73ea7a58778fa7acc5d9b6cbd6d66966"
      ]
    },
    {
      "id": "ent_070",
      "type": "Compound",
      "name": "IL-12",
      "attributes": {
        "context": "IL-8, IL-12"
      },
      "source_chunk_ids": [
        "73ea7a58778fa7acc5d9b6cbd6d66966"
      ]
    },
    {
      "id": "ent_071",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {
        "context": "IL-12, TNF-\u03b1"
      },
      "source_chunk_ids": [
        "73ea7a58778fa7acc5d9b6cbd6d66966"
      ]
    },
    {
      "id": "ent_072",
      "type": "Compound",
      "name": "interferon-gamma",
      "attributes": {
        "context": "TNF-\u03b1, interferon-gamma (IFN-\u03b3)"
      },
      "source_chunk_ids": [
        "73ea7a58778fa7acc5d9b6cbd6d66966"
      ]
    },
    {
      "id": "ent_073",
      "type": "Compound",
      "name": "MCP-1",
      "attributes": {
        "context": "IFN-\u03b3) and MCP-1"
      },
      "source_chunk_ids": [
        "73ea7a58778fa7acc5d9b6cbd6d66966"
      ]
    },
    {
      "id": "ent_074",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "after LPS challenge"
      },
      "source_chunk_ids": [
        "49d91f70273e44e6891d12d993e069c3"
      ]
    },
    {
      "id": "ent_075",
      "type": "PharmEffect",
      "name": "monocyte mitochondrial viability decreased",
      "attributes": {
        "context": "monocyte mitochondrial viability decreased significantly"
      },
      "source_chunk_ids": [
        "49d91f70273e44e6891d12d993e069c3"
      ]
    },
    {
      "id": "ent_076",
      "type": "Compound",
      "name": "TrimesemineTM",
      "attributes": {
        "context": "TrimesemineTM did not exert"
      },
      "source_chunk_ids": [
        "49d91f70273e44e6891d12d993e069c3"
      ]
    },
    {
      "id": "ent_077",
      "type": "PharmEffect",
      "name": "cytotoxic effects",
      "attributes": {
        "context": "did not exert cytotoxic effects"
      },
      "source_chunk_ids": [
        "49d91f70273e44e6891d12d993e069c3"
      ]
    },
    {
      "id": "ent_078",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "physiological effect of Sceletium"
      },
      "source_chunk_ids": [
        "0394bca466adefccd5d373d4ba9a32de"
      ]
    },
    {
      "id": "ent_079",
      "type": "Compound",
      "name": "TrimesemineTM",
      "attributes": {
        "context": "TrimesemineTM treatment conferred cytoprotective effects"
      },
      "source_chunk_ids": [
        "0394bca466adefccd5d373d4ba9a32de"
      ]
    },
    {
      "id": "ent_080",
      "type": "PharmEffect",
      "name": "cytoprotective effects",
      "attributes": {
        "context": "conferred cytoprotective effects onto immune cells"
      },
      "source_chunk_ids": [
        "0394bca466adefccd5d373d4ba9a32de"
      ]
    },
    {
      "id": "ent_081",
      "type": "Indication",
      "name": "acute endotoxin stimulation",
      "attributes": {
        "context": "presence of acute endotoxin stimulation"
      },
      "source_chunk_ids": [
        "0394bca466adefccd5d373d4ba9a32de"
      ]
    },
    {
      "id": "ent_082",
      "type": "PharmEffect",
      "name": "maintaining XTT viability",
      "attributes": {
        "context": "thus maintaining XTT viability at control levels"
      },
      "source_chunk_ids": [
        "0394bca466adefccd5d373d4ba9a32de"
      ]
    },
    {
      "id": "ent_083",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "LPS is known to activate immune cells"
      },
      "source_chunk_ids": [
        "0394bca466adefccd5d373d4ba9a32de"
      ]
    },
    {
      "id": "ent_084",
      "type": "PharmEffect",
      "name": "activate immune cells",
      "attributes": {
        "context": "LPS is known to activate immune cells"
      },
      "source_chunk_ids": [
        "0394bca466adefccd5d373d4ba9a32de"
      ]
    },
    {
      "id": "ent_085",
      "type": "Compound",
      "name": "Toll-like receptor 4",
      "attributes": {
        "context": "binding to Toll-like receptor 4"
      },
      "source_chunk_ids": [
        "0394bca466adefccd5d373d4ba9a32de"
      ]
    },
    {
      "id": "ent_086",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "Sceletium may protect host immune cells"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_087",
      "type": "PharmEffect",
      "name": "protect host immune cells",
      "attributes": {
        "context": "Sceletium may protect host immune cells"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_088",
      "type": "PharmEffect",
      "name": "rid the host of the pathogen",
      "attributes": {
        "context": "to more efficiently rid the host of the pathogen"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_089",
      "type": "PharmEffect",
      "name": "less severe clinical symptoms",
      "attributes": {
        "context": "with less severe clinical symptoms"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_090",
      "type": "Compound",
      "name": "nitric oxide",
      "attributes": {
        "context": "protected from the nitric oxide"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_091",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "in response to LPS"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_092",
      "type": "Indication",
      "name": "sterile inflammation",
      "attributes": {
        "context": "context of sterile inflammation"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_093",
      "type": "Indication",
      "name": "chronic diseases",
      "attributes": {
        "context": "many chronic diseases are characterised"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_094",
      "type": "PharmEffect",
      "name": "oxidative stress",
      "attributes": {
        "context": "increased levels of oxidative stress"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_095",
      "type": "Indication",
      "name": "low-grade inflammation",
      "attributes": {
        "context": "low-grade inflammation"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_096",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "potential for Sceletium to also have antioxidant capacity"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_097",
      "type": "PharmEffect",
      "name": "antioxidant capacity",
      "attributes": {
        "context": "have antioxidant capacity"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_098",
      "type": "PharmEffect",
      "name": "anti-stress effects",
      "attributes": {
        "context": "its illustrated anti-stress and anti-anxiety effects"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_099",
      "type": "PharmEffect",
      "name": "anti-anxiety effects",
      "attributes": {
        "context": "its illustrated anti-stress and anti-anxiety effects"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_100",
      "type": "Indication",
      "name": "modern lifestyle-associated diseases",
      "attributes": {
        "context": "effects of many modern lifestyle-associated diseases"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_101",
      "type": "PharmEffect",
      "name": "cytoprotective effect",
      "attributes": {
        "context": "striking cytoprotective effect of Sceletium"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_102",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "cytoprotective effect of Sceletium"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_103",
      "type": "PharmEffect",
      "name": "modulatory effects",
      "attributes": {
        "context": "significant desired modulatory effects in the context of inflammatory signalling"
      },
      "source_chunk_ids": [
        "7d51406da3c5554556511125508bfd2b"
      ]
    },
    {
      "id": "ent_104",
      "type": "Compound",
      "name": "Trimesemine\u2122",
      "attributes": {
        "context": "Trimesemine\u2122 up-regulated"
      },
      "source_chunk_ids": [
        "e8c042f34fad492e0154bb7442055dc6"
      ]
    },
    {
      "id": "ent_105",
      "type": "PharmEffect",
      "name": "up-regulated basal IL-10 secretion",
      "attributes": {
        "context": "Trimesemine\u2122 up-regulated basal IL-10 secretion"
      },
      "source_chunk_ids": [
        "e8c042f34fad492e0154bb7442055dc6"
      ]
    },
    {
      "id": "ent_106",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "this Sceletium extract"
      },
      "source_chunk_ids": [
        "b2c6845dcc2b8c25dedf42d1dd31b5b2"
      ]
    },
    {
      "id": "ent_107",
      "type": "PharmEffect",
      "name": "anti-inflammatory",
      "attributes": {
        "context": "possesses mild anti-inflammatory potential"
      },
      "source_chunk_ids": [
        "b2c6845dcc2b8c25dedf42d1dd31b5b2"
      ]
    },
    {
      "id": "ent_108",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "response to LPS stimulation"
      },
      "source_chunk_ids": [
        "b2c6845dcc2b8c25dedf42d1dd31b5b2"
      ]
    },
    {
      "id": "ent_109",
      "type": "Compound",
      "name": "Trimesemine\u2122",
      "attributes": {
        "context": "presence of Trimesemine\u2122"
      },
      "source_chunk_ids": [
        "b2c6845dcc2b8c25dedf42d1dd31b5b2"
      ]
    },
    {
      "id": "ent_110",
      "type": "Compound",
      "name": "IL-10",
      "attributes": {
        "context": "up-regulation of IL-10 secretion"
      },
      "source_chunk_ids": [
        "b2c6845dcc2b8c25dedf42d1dd31b5b2"
      ]
    },
    {
      "id": "ent_111",
      "type": "Compound",
      "name": "IL-6",
      "attributes": {
        "context": "increased IL-6 production"
      },
      "source_chunk_ids": [
        "b2c6845dcc2b8c25dedf42d1dd31b5b2"
      ]
    },
    {
      "id": "ent_112",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "induced by LPS"
      },
      "source_chunk_ids": [
        "b2c6845dcc2b8c25dedf42d1dd31b5b2"
      ]
    },
    {
      "id": "ent_113",
      "type": "Compound",
      "name": "Trimesemine\u2122",
      "attributes": {
        "context": "modulation by Trimesemine\u2122"
      },
      "source_chunk_ids": [
        "b2c6845dcc2b8c25dedf42d1dd31b5b2"
      ]
    },
    {
      "id": "ent_114",
      "type": "Indication",
      "name": "pathogenic challenge",
      "attributes": {
        "context": "immune response to an acute, pathogenic challenge"
      },
      "source_chunk_ids": [
        "b2c6845dcc2b8c25dedf42d1dd31b5b2"
      ]
    },
    {
      "id": "ent_115",
      "type": "Compound",
      "name": "Trimesemine\u2122",
      "attributes": {
        "context": "high-dose Trimesemine\u2122 appeared to result"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_116",
      "type": "Compound",
      "name": "IL-6",
      "attributes": {
        "context": "smaller IL-6 response to LPS"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_117",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "IL-6 response to LPS"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_118",
      "type": "Compound",
      "name": "IL-10",
      "attributes": {
        "context": "decreased monocyte IL-10 secretion"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_119",
      "type": "PharmEffect",
      "name": "smaller IL-6 response",
      "attributes": {
        "context": "result in a smaller IL-6 response"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_120",
      "type": "PharmEffect",
      "name": "decreased monocyte IL-10 secretion",
      "attributes": {
        "context": "resulted also in decreased monocyte IL-10 secretion"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_121",
      "type": "Concentration",
      "name": "high-dose",
      "attributes": {
        "context": "high-dose Trimesemine\u2122 appeared"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_122",
      "type": "PharmEffect",
      "name": "pro-inflammatory cytokines",
      "attributes": {
        "context": "secrete pro-inflammatory cytokines significantly"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_123",
      "type": "PharmEffect",
      "name": "limited inflammatory cytokine response",
      "attributes": {
        "context": "The more limited inflammatory cytokine response to LPS"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_124",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "inflammatory cytokine response to LPS"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_125",
      "type": "Compound",
      "name": "Trimesemine\u2122",
      "attributes": {
        "context": "presence of higher dose Trimesemine\u2122"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_126",
      "type": "Concentration",
      "name": "higher dose",
      "attributes": {
        "context": "presence of higher dose Trimesemine\u2122"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_127",
      "type": "PharmEffect",
      "name": "limit the undesired symptomatic effects of the inflammatory hyper-response",
      "attributes": {
        "context": "may limit the undesired symptomatic effects of the inflammatory hyper-response"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_128",
      "type": "PharmEffect",
      "name": "inflammatory hyper-response",
      "attributes": {
        "context": "symptomatic effects of the inflammatory hyper-response to LPS"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_129",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "inflammatory hyper-response to LPS"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_130",
      "type": "PharmEffect",
      "name": "detrimental immunosuppression",
      "attributes": {
        "context": "result of detrimental immunosuppression"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_131",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "increased in response to LPS"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_132",
      "type": "Concentration",
      "name": "high dose",
      "attributes": {
        "context": "the high dose employed in the current study"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_133",
      "type": "Concentration",
      "name": "supraphysiological dose",
      "attributes": {
        "context": "represents a supraphysiological dose"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_134",
      "type": "Concentration",
      "name": "at least 100-fold higher than suggested daily",
      "attributes": {
        "context": "at least 100-fold higher than suggested daily"
      },
      "source_chunk_ids": [
        "02dd3e80b33307755b891893b3eb7fbd"
      ]
    },
    {
      "id": "ent_135",
      "type": "Compound",
      "name": "serotonin/5-hydroxytryptamine (5-HT)",
      "attributes": {
        "context": "serotonin/5-hydroxytryptamine (5-HT) turnover"
      },
      "source_chunk_ids": [
        "47d598f50f701de28146936c8a31aa2c"
      ]
    },
    {
      "id": "ent_136",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "involved in depression"
      },
      "source_chunk_ids": [
        "47d598f50f701de28146936c8a31aa2c"
      ]
    },
    {
      "id": "ent_137",
      "type": "Compound",
      "name": "mesembrine",
      "attributes": {
        "context": "a high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_138",
      "type": "Taxon",
      "name": "Sceletium",
      "attributes": {
        "context": "a high-mesembrine Sceletium extract"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_139",
      "type": "Compound",
      "name": "Trimesemine\u2122",
      "attributes": {
        "context": "Trimesemine\u2122, beneficially modulates"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_140",
      "type": "PharmEffect",
      "name": "anti-inflammatory",
      "attributes": {
        "context": "modulates the basal inflammatory cytokine profile"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_141",
      "type": "PharmEffect",
      "name": "anti-oxidant activity",
      "attributes": {
        "context": "may affect anti-oxidant activity"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_142",
      "type": "PharmEffect",
      "name": "cytoprotection",
      "attributes": {
        "context": "conferring significant cytoprotection"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_143",
      "type": "Compound",
      "name": "endotoxin",
      "attributes": {
        "context": "from endotoxin-associated oxidative stress damage"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_144",
      "type": "Compound",
      "name": "LPS",
      "attributes": {
        "context": "increased LPS levels"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_145",
      "type": "Indication",
      "name": "pathogenic infection",
      "attributes": {
        "context": "in pathogenic infection"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_146",
      "type": "Indication",
      "name": "chronic diseases",
      "attributes": {
        "context": "in chronic diseases"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_147",
      "type": "Indication",
      "name": "Alzheimer's disease",
      "attributes": {
        "context": "such as Alzheimer's disease"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_148",
      "type": "Indication",
      "name": "arthritis",
      "attributes": {
        "context": "arthritis (Azzouz and Silverman, 2017)"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_149",
      "type": "Indication",
      "name": "depression",
      "attributes": {
        "context": "and depression (Zhou et al., 2018)"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    },
    {
      "id": "ent_150",
      "type": "Compound",
      "name": "Trimesemine\u2122",
      "attributes": {
        "context": "role for Trimesemine\u2122"
      },
      "source_chunk_ids": [
        "e3ffacb4ef7c5c0745a5e05e89ea5afd"
      ]
    }
  ],
  "relationships": [],
  "metadata": {
    "migration_date": "2026-02-02T08:40:04.002311+00:00",
    "original_file": "entities.json"
  }
}